REBECCA OLAUGHLIN: Open Payments
NPI 1225766835 · FOREST HILL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 26 payments from 11 companies in 2025. Trend: 2023 $1,131 · 2024 $1,367 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $153 |
| Novo Nordisk Inc | 4 | $90 |
| Amgen Inc. | 5 | $83 |
| Lilly USA, LLC | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| PFIZER INC. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
| Dexcom, Inc. | 1 | $21 |
Products named: FARXIGA, AIRSUPRA, EVENITY, MOUNJARO, REXULTI, Ozempic, Wegovy, OTEZLA.
Industry payments across MD — which companies pay providers there.
